These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 20182772

  • 21. Phenethyl Isothiocyanate Inhibits In Vivo Growth of Xenograft Tumors of Human Glioblastoma Cells.
    Chou YC, Chang MY, Lee HT, Shen CC, Harnod T, Liang YJ, Wu RS, Lai KC, Hsu FT, Chung JG.
    Molecules; 2018 Sep 10; 23(9):. PubMed ID: 30201893
    [Abstract] [Full Text] [Related]

  • 22. Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases.
    Xiao D, Singh SV.
    Cancer Res; 2002 Jul 01; 62(13):3615-9. PubMed ID: 12097262
    [Abstract] [Full Text] [Related]

  • 23. Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model.
    Stan SD, Singh SV, Whitcomb DC, Brand RE.
    Nutr Cancer; 2014 Jul 01; 66(4):747-55. PubMed ID: 24195616
    [Abstract] [Full Text] [Related]

  • 24. Phenethyl isothiocyanate (PEITC) promotes G2/M phase arrest via p53 expression and induces apoptosis through caspase- and mitochondria-dependent signaling pathways in human prostate cancer DU 145 cells.
    Tang NY, Huang YT, Yu CS, Ko YC, Wu SH, Ji BC, Yang JS, Yang JL, Hsia TC, Chen YY, Chung JG.
    Anticancer Res; 2011 May 01; 31(5):1691-702. PubMed ID: 21617228
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin.
    Kim JH, Xu C, Keum YS, Reddy B, Conney A, Kong AN.
    Carcinogenesis; 2006 Mar 01; 27(3):475-82. PubMed ID: 16299382
    [Abstract] [Full Text] [Related]

  • 26. Notch activation by phenethyl isothiocyanate attenuates its inhibitory effect on prostate cancer cell migration.
    Kim SH, Sehrawat A, Sakao K, Hahm ER, Singh SV.
    PLoS One; 2011 Mar 01; 6(10):e26615. PubMed ID: 22039516
    [Abstract] [Full Text] [Related]

  • 27. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
    Li X, Wu JB, Chung LW, Huang WC.
    Oncotarget; 2015 Dec 01; 6(38):41018-32. PubMed ID: 26512780
    [Abstract] [Full Text] [Related]

  • 28. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
    Hahm ER, Arlotti JA, Marynowski SW, Singh SV.
    Clin Cancer Res; 2008 Feb 15; 14(4):1248-57. PubMed ID: 18281560
    [Abstract] [Full Text] [Related]

  • 29. Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin.
    Wang X, Govind S, Sajankila SP, Mi L, Roy R, Chung FL.
    Mol Nutr Food Res; 2011 Oct 15; 55(10):1572-81. PubMed ID: 21595016
    [Abstract] [Full Text] [Related]

  • 30. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction.
    Xiao D, Lew KL, Kim YA, Zeng Y, Hahm ER, Dhir R, Singh SV.
    Clin Cancer Res; 2006 Nov 15; 12(22):6836-43. PubMed ID: 17121905
    [Abstract] [Full Text] [Related]

  • 31. Phenethyl isothiocyanate induced apoptosis via down regulation of Bcl-2/XIAP and triggering of the mitochondrial pathway in MCF-7 cells.
    Lee JW, Cho MK.
    Arch Pharm Res; 2008 Dec 15; 31(12):1604-12. PubMed ID: 19099231
    [Abstract] [Full Text] [Related]

  • 32. Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer.
    Powolny AA, Bommareddy A, Hahm ER, Normolle DP, Beumer JH, Nelson JB, Singh SV.
    J Natl Cancer Inst; 2011 Apr 06; 103(7):571-84. PubMed ID: 21330634
    [Abstract] [Full Text] [Related]

  • 33. Effects of antioxidants and caspase-3 inhibitor on the phenylethyl isothiocyanate-induced apoptotic signaling pathways in human PLC/PRF/5 cells.
    Wu SJ, Ng LT, Lin CC.
    Eur J Pharmacol; 2005 Aug 22; 518(2-3):96-106. PubMed ID: 16054126
    [Abstract] [Full Text] [Related]

  • 34. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.
    Henry JY, Lu L, Adams M, Meyer B, Bartlett JB, Dalgleish AG, Galustian C.
    Prostate; 2012 Jun 01; 72(8):856-67. PubMed ID: 21968939
    [Abstract] [Full Text] [Related]

  • 35. HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo.
    Ikezoe T, Hisatake Y, Takeuchi T, Ohtsuki Y, Yang Y, Said JW, Taguchi H, Koeffler HP.
    Cancer Res; 2004 Oct 15; 64(20):7426-31. PubMed ID: 15492266
    [Abstract] [Full Text] [Related]

  • 36. Histone deacetylase inhibitor potentiates anticancer effect of docetaxel via modulation of Bcl-2 family proteins and tubulin in hormone refractory prostate cancer cells.
    Hwang JJ, Kim YS, Kim MJ, Kim DE, Jeong IG, Kim CS.
    J Urol; 2010 Dec 15; 184(6):2557-64. PubMed ID: 21030039
    [Abstract] [Full Text] [Related]

  • 37. Modulation of growth of human prostate cancer cells by the N-acetylcysteine conjugate of phenethyl isothiocyanate.
    Chiao JW, Chung F, Krzeminski J, Amin S, Arshad R, Ahmed T, Conaway CC.
    Int J Oncol; 2000 Jun 15; 16(6):1215-9. PubMed ID: 10811998
    [Abstract] [Full Text] [Related]

  • 38. Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer.
    Howard EW, Lee DT, Chiu YT, Chua CW, Wang X, Wong YC.
    Int J Cancer; 2008 May 01; 122(9):1941-8. PubMed ID: 18183597
    [Abstract] [Full Text] [Related]

  • 39. [Expression of AXL enhances docetaxel-resistance of prostate cancer cells].
    Lin JZ, Zhu JG, Wu HF, Li JM, DE W, Wang ZJ.
    Zhonghua Nan Ke Xue; 2017 Apr 01; 23(4):302-308. PubMed ID: 29714413
    [Abstract] [Full Text] [Related]

  • 40. Phenethyl isothiocyanate potentiates anti-tumour effect of doxorubicin through Akt-dependent pathway.
    Eisa NH, ElSherbiny NM, Shebl AM, Eissa LA, El-Shishtawy MM.
    Cell Biochem Funct; 2015 Dec 01; 33(8):541-51. PubMed ID: 26548747
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.